On the contrary, activation of peroxisome proliferator–activated receptor γ (PPARγ) with the synthetic ligand rosiglitazone attenuates hypoxia-induced increases in mouse lung NOX4 expression, ROS generation and pulmonary vascular remodeling and hypertension [45]. The gene discussed is NOX4; the disease is hypertensive disorder.